Polycystic ovary syndrome: an overview

Area of Science:

• Endocrinology
• Reproductive Health
• Metabolic Disorders

Background:

• Polycystic ovary syndrome (PCOS) is the most prevalent endocrine disorder among women of reproductive age, affecting 6-7% of this demographic.
• PCOS is characterized by hyperandrogenism and ovarian dysfunction, frequently co-occurring with insulin resistance and obesity.
• The presence of these comorbidities highlights the critical need for healthcare providers to monitor patients for metabolic syndrome and type 2 diabetes.

Purpose of the Study:

• To outline the key characteristics and diagnostic considerations for PCOS.
• To detail the multifaceted treatment strategies for PCOS.
• To emphasize the importance of managing metabolic and cardiovascular risks in women with PCOS.

Main Methods:

• Review of current literature on PCOS pathophysiology and clinical management.
• Analysis of treatment approaches targeting hyperandrogenism, insulin resistance, and reproductive dysfunction.
• Emphasis on lifestyle modifications and pharmacotherapy.

Main Results:

• Effective PCOS management requires a comprehensive approach addressing hormonal imbalances, metabolic dysfunction, and reproductive health.
• Weight management through diet and exercise is a cornerstone of PCOS treatment, irrespective of BMI.
• Pharmacological interventions may be used adjunctively to manage specific symptoms and reduce long-term health risks.

Conclusions:

• Integrated management strategies are essential for PCOS patients, focusing on improving insulin sensitivity and reducing hyperandrogenic symptoms.
• Long-term monitoring and proactive interventions are crucial to mitigate the increased risk of metabolic syndrome, type 2 diabetes, and cardiovascular disease in women with PCOS.
• Pharmacists play a vital role in educating patients and ensuring adherence to treatment plans for optimal outcomes.